Aldeyra Therapeutics Reports Expansion of Drug Development Team Ahead of NS2 Clinical Trials
September 02, 2014 at 08:31 AM EDT
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases ...